Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes

Circulation

Volumn 98, Issue 21, 1998, Pages 2314-2322

  Shimizu, Wataru ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Arrhythmia; Chromanol 293b; Isoproterenol; KvLQT1; Long QT syndrome

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHROMANOL 293 B; ISOPRENALINE; MEXILETINE; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION THERAPY; HEART REPOLARIZATION; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0344863069     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.21.2314     Document Type: Article

References (14)

1. Schwartz PJ, Malliani A. Electrical alterations of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J. 1975;89:45-50.
2. Crampton RS. Preeminence of the left stellate ganglion in the long Q-T syndrome. Circulation. 1979;59:769-778.
3. Schwartz PJ. The idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
4. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer JW, Hall WJ, Weitkamp LR, Vincent GM, Garson A, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
5. Zipes DP. The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation. 1991;84:1414-1419.
6. Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995:788-811.
7. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM, for the SADS Foundation Task Force on LQTS. Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation. 1996;94:1996-2012.
8. Wang Q, Shen J, Splawski I, Atkinson DL, Li ZZ, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
9. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
10. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, Van Raay TJ, Shen J, Timothy KW, Vincent GM, De Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17-23.
11. Ks function. Nat Genet. 1997;17:338-340.
12. Kr potassium channel. Cell. 1995;81:299-307.
13. Ks potassium channel. Nature. 1996;384:80-83.
14. Ks cardiac potassium current. Nature. 1996;384:78-80.